Fluoroquinolone antimicrobial drugs
- PMID: 28461376
- PMCID: PMC5415392
- DOI: 10.1503/cmaj.160938
Fluoroquinolone antimicrobial drugs
Conflict of interest statement
Competing interests: None declared.
References
-
- Hooper DC. New uses for new and old quinolones and the challenge of resistance. Clin Infect Dis 2000;30:243–54. - PubMed
-
- FDA Drug Safety Communication: FDA advises restricting fluoroquinolone antibiotic use for certain uncomplicated infections; warns about disabling side effects that can occur together. Silver Spring (MD): US Food and Drug Administration, Center for Drug Evaluation and Research; updated 2016. Available: www.fda.gov/Drugs/DrugSafety/ucm500143.htm (accessed 2016 May 27).
-
- Canadian Antimicrobial Resistance Surveillance System — report 2016. Ottawa: Public Health Agency of Canada; 2016.
-
- Karlowsky JA, Hoban DJ, DeCorby MR, et al. Fluoroquino-lone-resistant urinary isolates of Escherichia coli from out-patients are frequently multidrug resistant: results from the North American Urinary Tract Infection Collaborative Alliance-Quinolone Resistance Study. Antimicrob Agents Chemother 2006;50:2251–4. - PMC - PubMed
-
- Lipsky BA, Baker CA. Fluoroquinolone toxicity profiles: a review focusing on newer agents. Clin Infect Dis 1999; 28:352–64. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical